72067423CA00005
Cooperative Agreement
Overview
Grant Description
The purpose of this activity will be to close the gaps to HIV epidemic control. Sustain health gains through strengthened, improved, and resilient health systems. And leverage community, civil society, and private sector partnerships to improve and sustain service delivery and client outcomes in Limpopo Province.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
South Africa
Geographic Scope
Foreign
Related Opportunity
Analysis Notes
Termination This cooperative agreement was reported as terminated by the Department of Government Efficiency (DOGE) in July 2025. See All
Amendment Since initial award the total obligations have increased 800% from $2,200,000 to $19,794,050.
Amendment Since initial award the total obligations have increased 800% from $2,200,000 to $19,794,050.
Anova Health Institute was awarded
HIV Epidemic Control Health System Strengthening in Limpopo Province
Cooperative Agreement 72067423CA00005
worth $19,794,050
from U.S. Mission to South Africa in October 2023 with work to be completed primarily in South Africa.
The grant
has a duration of 5 years and
was awarded through assistance program 98.001 USAID Foreign Assistance for Programs Overseas.
The Cooperative Agreement was awarded through grant opportunity Achieving and Sustaining HIV/TB Epidemic Control in the Limpopo Province.
Status
(Ongoing)
Last Modified 1/13/25
Period of Performance
10/15/23
Start Date
10/14/28
End Date
Funding Split
$19.8M
Federal Obligation
$0.0
Non-Federal Obligation
$19.8M
Total Obligated
Activity Timeline
Transaction History
Modifications to 72067423CA00005
Additional Detail
Award ID FAIN
72067423CA00005
SAI Number
72067423CA00005-P004
Award ID URI
SAI NOT AVAILABLE
Awardee Classifications
Other
Awarding Office
720674 USAID/SOUTH AFRICA
Funding Office
720674 USAID/SOUTH AFRICA
Awardee UEI
KCSWDT8A1NH3
Awardee CAGE
SHB42
Performance District
Not Applicable
Modified: 1/13/25